- Les Irwig (lesi@health.usyd.edu.au), professor of epidemiology
- Screening and Test Evaluation Program, School of Public Health, University of Sydney, NSW 2006, Australia
Ayear ago, at the age of 55, I was diagnosed as having normal-tension glaucoma. I had an upper visual field loss in both eyes—about 20% of the field in the right eye and about 30 % in the left eye, in which the area of loss was close to the centre of the visual field and therefore potentially threatened fixation. This added to my lifelong myopia, which I now know is a risk factor for glaucoma. Like many patients with a chronic condition, I read extensively about glaucoma after receiving the diagnosis. However, I had the advantage of epidemiological expertise, a special interest in screening and diagnosis,1 2 and a deep-seated belief in the importance of patient involvement in decision making.3 I will discuss issues that were important to me as a patient and that highlight potential improvement in management. Many of these points may be generalisable to other chronic conditions. Health care often involves a partnership between practitioner and patient sharing the best evidence, deciding how to make decisions, and incorporating patient preferences.4

The correct procedure for using eyedrops: (left) pulling open the bottom eyelid to insert the drops and (right) pressing on the tearduct for two minutes to prevent drainage into the nose/mouth
MEDISCAN/DANIEL GEE
How should I decide whether to start treatment and, if so, which treatment?
Randomised trials show that pressure reduction by drugs, or trabeculoplasty by laser or surgery, will slow the loss of the visual field.5 6 Deciding whether to start treatment, and if so which treatment, depends on the extent to which the benefits outweigh the harm of adverse effects of treatment. If my visual field loss was stable rather than progressive, treatment would involve harm without any potential for benefit. Ophthalmological opinion was …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012